XML 82 R53.htm IDEA: XBRL DOCUMENT v3.25.0.1
Shareholders' Equity (Tables)
12 Months Ended
Dec. 31, 2024
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Schedule of changes in share capital

Number

  

  

of shares

  

  

Amount

 

Balance at January 1, 2023

 

191,892,691

$

5,695.3

Exercise of stock options

61,000

3.8

Dividend reinvestment plan

221,351

29.1

Balance at December 31, 2023

192,175,042

$

5,728.2

Balance at January 1, 2024

192,175,042

$

5,728.2

Exercise of stock options

71,864

3.6

Vesting of restricted share units

18,340

2.7

Dividend reinvestment plan

287,449

34.6

Balance at December 31, 2024

192,552,695

$

5,769.1

Schedule of dividends paid

  

  

2024

  

  

2023

  

Cash dividends

$

242.4

$

233.0

DRIP dividends

 

34.6

 

29.1

$

277.0

$

262.1

Schedule of options to purchase common shares that have been granted

  

  

    

Weighted

  

average exercise

Number

price

Stock options outstanding, at January 1, 2023

 

724,653

C$

107.34

Granted

 

5,548

 

C$

169.78

Exercised

 

(61,000)

 

C$

64.50

Stock options outstanding, at December 31, 2023

 

669,201

 

C$

111.76

Stock options outstanding, at January 1, 2024

669,201

C$

111.76

Granted

45,396

 

C$

167.57

Exercised

(71,864)

 

C$

52.67

Forfeited

(10,353)

C$

180.58

Stock options outstanding, at December 31, 2024

 

632,380

 

C$

121.36

Exercisable stock options, at December 31, 2023

570,572

 

C$

100.51

Exercisable stock options, at December 31, 2024

 

524,919

 

C$

110.82

Schedule of fair value of options calculated using Black-Scholes option pricing model and weighted average assumptions utilized

2024

2023

Risk-free interest rate

3.08

%

4.08

%

Expected dividend yield

1.20

%

1.10

%

Expected price volatility of the Company’s common shares

26.4

%

30.9

%

Expected life of the option

 

4 years

4 years

Forfeiture rate

0

%

0

%

Schedule of options to purchase common shares outstanding, exercise prices and weighted average lives to maturity

    

    

    

Weighted

 

Exercise

Options

Options

average life

 

price

outstanding

exercisable

(years)

 

C$59.52 to C$82.11

 

173,414

 

173,414

 

1.50

C$82.12 to C$97.34

 

99,303

 

99,303

 

3.73

C$97.35 to C$141.97

 

127,878

 

127,878

 

4.08

C$141.98 to C$171.04

 

117,772

 

42,565

 

6.96

C$171.05 to C$194.65

 

114,013

 

81,759

 

5.95

    

632,380

    

524,919

    

3.69

Schedule of number of shares outstanding

  

Performance-

    

Time-based

    

  

based RSUs

    

RSUs

    

Total RSUs

Balance at January 1, 2023

71,051

31,053

102,104

Granted

Settled

Balance at December 31, 2023

71,051

31,053

102,104

Balance at January 1, 2024

71,051

31,053

102,104

Granted

29,694

20,744

50,438.00

Settled

(2,639)

(15,701)

(18,340.00)

Forfeited

(22,086)

(757)

(22,843.00)

Balance at December 31, 2024

76,020

35,339

111,359

Schedule of share purchase warrants

At December 31, 

At December 31, 

  

  

2024

  

  

2023

 

Common shares outstanding

 

192,552,695

192,175,042

Stock options(1)

632,380

669,201

Restricted Share Units(2)

111,359

102,104

193,296,434

192,946,347

1There were 632,380 stock options under our share compensation plan outstanding to directors, officers, employees and others with exercise prices ranging from C$59.52 to C$194.65 per share. The above table assumes all stock options are exercisable.
2There were 35,339 time-based RSUs and 76,020 performance-based RSUs. Vesting of the performance-based RSUs are subject to the achievement of certain performance criteria and a performance multiplier which will range from 0% to 150% of the number granted. The above table assumes a performance multiplier of 100% of performance-based RSUs granted.
DSU plan  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Schedule of number of shares outstanding

  

  

2024

  

  

2023

 

Balance at beginning of year

 

119,429

110,128

Granted

13,975

11,816

Settled

(38,568)

(2,515)

Balance at end of year

94,836

119,429